Cancer Care Delivery Reform:The Payer’s Perspective
Quality health plans & benefitsHealthier livingFinancial well-beingIntelligent solutions
Michael Kolodziej, MD, FACPNational Medical Director, Oncology Solutions, Aetna
Aetna Inc.
We put people at the center of everything we do
This presentation outlines how we can help members and providers optimize cancer care
2
The rising cost of cancer care is everyone’s problem
Cancer care is the leading edge of medical cost trend
Medical Rx30.8%1.5 B
Aetna’s top cost drivers in cancer care
Radiology 22.4%1.1 B
Inpatient23.3%1.1 B
Specialist physician9.4%
483 M
Annual increase
Cancer drugs 20%Cancer medical 12-18%Health care 9%US GDP 3%
1996 20100%
1000% $55 B
$123 B
Cumulative percentage increase
*2010 CY Claims; Commercial & Medicare; All Funding; Excludes AGB/SH/SRC
www.cancer.gov/newscenter/pressreleases/2011/CostCancer2020
Aetna Inc. 3
Aetna Inc. 4
Principles of our proposed strategy
• Drive efficient use of evidence-based medicine– platform that provides content and workflows– integrate into the Aetna and provider systems – simplify the administrative processes for providers
• Avoid waste and misuse of medical services – better provider alignment
(e.g., Oncology Patient Centered Medical Home), – better network (narrow, tiered)– better decision support strategies
• Leverage and integrate the many current (and future) medical and pharmacy cancer-care initiatives
– seamless, end to end cancer experience for Aetna members and providers
Aetna Inc. 5
Aetna Inc.
Increased adherence to evidence based guidelines lowers cost without negatively impacting treatment efficacyStudy: “Cost Effectiveness of Evidence-Based Treatment Guidelines for the Treatment of Non–Small-Cell Lung Cancer in the Community Setting”
Published: Journal of Oncology Practice (ASCO Peer Reviewed Journal), 1/19/2010
No change in overall survival between the study groups
Source: “Cost Effectiveness of Evidence-Based Treatment Guidelines for the Treatment of Non–Small-Cell Lung Cancer in the Community Setting”. Journal of Oncology Practice. January 2010. Volume 6. No.1. p 12-18
Significantly lowered cost in the case group vs. The control group
Purpose: Evaluate the cost effectiveness of evidence-based treatment pathways for NSCLC patients
Conclusion: Results of this study suggest that treating patients according to evidence-based guidelines is a cost-effective strategy for delivering care to those with NSCLC.
Overall survival by Pathway status.
6
Medical management Pathways and evidence based medicine
Clinical pathways are treatment roadmaps of best care practices
• Developed through research and medical evidence
• Provide physicians a more precise approach to cancer care
• Pathway treatment comparison─ Efficacy─ Toxicity (side effects)─ Cost (utilizing generics)
• Pathway lines of therapy─ Combination of drugs
used and the sequencing of how they are given
─ Appropriateness of when to begin treatment and when to discontinue treatment
─ A new line of therapy is generally used when a pathway did not meet clinical outcomes or the cancer progresses
Medical management model*
Pharmacystrategy
Commun-ications
Plan design
Networkdesign
Customerservice
Aetna Inc. 7
Aetna Inc.
Platform: Enable administrative easing of prior authorization/pre-certification for practices on the platform
iNexx Platformeviti app
Physician accesses vendor CDS
EBM treatment
plan is built
Oncology clinical decision support
Vendor payer portal
Automated “CDS-code” is delivered
Email notification in near real-time to Aetna UM
Locate CDS code information
Enter CDS code information
etums/ ATV
EDI
Claims processing
Pended via 278 transaction
2
1
5 6
4
3a 3b
Vendor clearing house
270/271 transaction
Local administrator in claims processing can be established
8
Aetna Inc. 9
What are the PCMH joint principles?• Personal physician
— Each patient has an ongoing relationship with a personal physician— Personal physician leads a team of individuals that takes responsibility
for the ongoing care of patients— Personal physician is responsible for providing for all the patient’s
health care needs or arranging care with other qualified professionals
• Care is coordinated across health care system
• Quality and safety are hallmarks of the medical home
• Enhanced access to care is available through systems such as open scheduling, expanded hours and new options for communication
• Payment recognizes the added value provided to patients who have a patient-centered medical home
Aetna Inc. 10
Expected benefits to health care consumers• Improved health outcomes supported by doctors’ use of clinical decision-
support tools to improve care management, tracking and adherence to evidence-based guidelines
• Reduced hospitalizations and ambulatory care— Includes primary and readmissions— Includes sensitive specialty/facility and other costs
• Improved transition of care
• Shared decision making
• Increased engagement in preventive health and wellness
Aetna Inc. 11
Aetna Inc.
Medical managementWhat about Oncology medical homes?
Measurements would be those defined initially by the Community Oncology Alliance group such as:
• Percentage adherence to clinical pathways• Percentage of patients with documented
clinical or pathologic staging prior to treatment
• Percentage of ER visits per patient per year• Percentage of Hospital admissions per
patient per year• Percentage of patient deaths occurring in
an acute setting• Average number of days in hospice prior to
death• Percentage of patients with stage IV that
have end-of-life care discussions
Define the components and measurement criteria for designating a provide practice as an Oncology Medical Home (OMH).
Basic components include: • Enhanced communication/patient
education• Coordination and easy patient
access to care• Case management responsibilities• Improved patient tracking of compliance
to medications and follow up activity• Reporting capabilities• NCQA recognition
Aetna Inc. 12
Aetna Inc.Emerging Businesses
We have the capabilities to equip oncologists with the tools to transition to a medical home
Care Management Support
Financial Alignment
Oncology Medical Home Solution
Information Technology
Value based contracting and benefit steerage to drive adoption
Clinical decision support tools to optimize care plan
Automated prior-authorization to reduce administrative burden
IT platform for care transitions and holistic view of patients
Optimal Staffing Model to provide leverage and coordinate care Oncology-tailored patient
applications to support patients
Prov
ider
Too
lsPa
tient
Too
lsH
IT P
latf
orm
13
Aetna Inc.
Impact of a cancer management program:an Innovent/Aetna pilot
Study Design• Prospective, non-randomized evaluation of patients enrolled in the Innovent Oncology Program
Location • Patients seen by Texas Oncology physicians
Study period• Innovent Oncology Program 6/1/2010-5/31/2012; Program yr 1: 6/1/2010- 5/31/2011; Program yr 2: 5/1/2011-4/31/2012
Inclusion
• Aetna eligible pts diagnosed with an Innovent diagnosis initiating chemotherapy during program year 1 or year 2• Drug costs• ER and in-patient admissions and costs
Exclusion
• Patient eligible for the program in the last month of each program year
• Patients with a chemotherapy claim in the month prior to the program year
• Patients without a chemotherapy claim within each program year
ASCO Quality, 2012 14
Aetna Inc.
Non-assessable 4%**
Off-pathway
24%
On-pathway
76%
Pathways Compliance
ASCO Quality, 2012 15
Bundles are likely the end result
Aetna Inc. 17
18
Bach, Health Affairs, 2011
Aetna Inc. 19
Aetna Inc.Emerging Businesses
ACO
We can also look to leverage ACS to serve oncology practices seeking shared savings through an ACO model
Oncology MH Solution:
Community Oncology Practice
+ Text Text
Text
Text
Oncology Practice
Hospital
Payor
Primary Care Practice
Aetna contracts with community oncology practices to become medical homes
1 Aetna leverages ACS to facilitate relationships between enabled oncology practices and ACOs
2
Enablement of oncology-specific component for ACOsB
20
The goal
Aetna Inc. 21
•Better quality•Lower cost•More value
The current (sorry) state of affairs
The Oncologist and his/her office is stuck in a 20th Century communication and Data exchange environment
Aetna Inc. 22
Aetna Inc.
Focus on the patient
Place the patient at the center of enhanced care delivery facilitated through the platform.As practices invite other providers to join their collaboration network, communication and services around their patient’s care are streamlined and simplified.
23
Aetna Inc.
Privately or Publicly-Sponsored Medicity Technology Connects Systems to Transform Data Into Action
Patient Portal
Analytics, Clinical Decision Support, Risk-stratified Populations & Quality Measures
Data Aggregation Community Health Record
Identity ManagementBio Surveillance
RegistriesPatient Consent Framework
24
iNexx® gives you the power to connect and create the care delivery system that you want
iNexx®ResultReferralOrder
Creating a more collaborative network of care giversVCTR
Aetna Inc. 25
Success will require multiple steps
1. Transformation of the clinical practice.2. Evolution of the hospital into an integrated delivery
system.3. Adoption of a culture that espouses performance
measurement and process improvement.4. Modernization of the IT platform, focused on payer,
provider and patient integration.5. Reformation of the reimbursement platform.6. Partnership.
Aetna Inc. 26